An Extension Study of Linifanib in Subjects With Advanced or Metastatic Solid Tumors.
Phase of Trial: Phase I
Latest Information Update: 24 Nov 2017
At a glance
- Drugs Linifanib (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 24 Nov 2017 Last checked against ClinicalTrials.gov record.
- 02 Aug 2012 Actual end date (Jun 2012) added as reported by ClinicalTrials.gov.
- 01 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.